World's Best Scientists 2026 revealed!
Michael A. Jakupec

Michael A. Jakupec

D-Index & Metrics

Chemistry

D-Index
77
Citations
19482
World Ranking
4068
National Ranking
17

Michael A. Jakupec publication distribution in Chemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Chemistry in 2026. The highlighted bar marks where Michael A. Jakupec sits on this spectrum.

61–80 publications: 66 scientists 81–100 publications: 302 scientists 101–120 publications: 623 scientists 121–140 publications: 918 scientists 141–160 publications: 1,218 scientists 161–180 publications: 1,350 scientists 181–200 publications: 1,344 scientists 201–220 publications: 1,281 scientists 221–240 publications: 1,216 scientists 241–260 publications: 1,100 scientists 261–280 publications: 979 scientists 281–300 publications: 939 scientists 301–320 publications: 764 scientists 321–340 publications: 643 scientists 341–360 publications: 628 scientists 361–380 publications: 522 scientists 381–400 publications: 459 scientists 401–420 publications: 397 scientists 421–440 publications: 327 scientists 441–460 publications: 270 scientists 461–480 publications: 265 scientists 481–500 publications: 252 scientists 501–520 publications: 201 scientists 521–540 publications: 185 scientists 541–560 publications: 148 scientists 561–580 publications: 148 scientists 581–600 publications: 132 scientists 601–620 publications: 114 scientists 621–640 publications: 104 scientists 641–660 publications: 91 scientists 661–680 publications: 92 scientists 681–700 publications: 73 scientists 701–720 publications: 57 scientists 721–740 publications: 54 scientists 741–760 publications: 67 scientists 761–780 publications: 45 scientists 781–800 publications: 46 scientists 801–820 publications: 39 scientists 821–840 publications: 32 scientists 841–860 publications: 36 scientists 861–880 publications: 29 scientists 881–900 publications: 26 scientists 901–920 publications: 24 scientists 921–940 publications: 14 scientists 941–960 publications: 23 scientists 961–980 publications: 28 scientists 981–1,000 publications: 15 scientists 1,001–1,020 publications: 29 scientists 1,021–1,040 publications: 12 scientists 1,041–1,060 publications: 19 scientists 1,061–1,080 publications: 12 scientists 1,081–1,100 publications: 6 scientists 1,101–1,120 publications: 8 scientists 1,121–1,140 publications: 12 scientists 1,141–1,160 publications: 5 scientists 1,161–1,180 publications: 6 scientists 1,181–1,200 publications: 14 scientists 1,201–1,220 publications: 7 scientists 1,221–1,240 publications: 2 scientists 1,241–1,260 publications: 6 scientists 1,261–1,280 publications: 4 scientists 1,281–1,294 publications: 6 scientists 1,295+ publications: 100 scientists
61 publications 1,295+

This scientist: 261 publications — 53rd percentile

53% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,295 publications or more.

Michael A. Jakupec D-index placement in Chemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Chemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Michael A. Jakupec sits on this spectrum.

40–41 D-Index: 289 scientists 42–43 D-Index: 612 scientists 44–45 D-Index: 808 scientists 46–47 D-Index: 776 scientists 48–49 D-Index: 835 scientists 50–51 D-Index: 861 scientists 52–53 D-Index: 872 scientists 54–55 D-Index: 933 scientists 56–57 D-Index: 1,051 scientists 58–59 D-Index: 930 scientists 60–61 D-Index: 882 scientists 62–63 D-Index: 834 scientists 64–65 D-Index: 731 scientists 66–67 D-Index: 775 scientists 68–69 D-Index: 683 scientists 70–71 D-Index: 646 scientists 72–73 D-Index: 561 scientists 74–75 D-Index: 501 scientists 76–77 D-Index: 437 scientists 78–79 D-Index: 388 scientists 80–81 D-Index: 354 scientists 82–83 D-Index: 292 scientists 84–85 D-Index: 275 scientists 86–87 D-Index: 254 scientists 88–89 D-Index: 235 scientists 90–91 D-Index: 185 scientists 92–93 D-Index: 192 scientists 94–95 D-Index: 155 scientists 96–97 D-Index: 163 scientists 98–99 D-Index: 125 scientists 100–101 D-Index: 105 scientists 102–103 D-Index: 105 scientists 104–105 D-Index: 112 scientists 106–107 D-Index: 88 scientists 108–109 D-Index: 68 scientists 110–111 D-Index: 69 scientists 112–113 D-Index: 65 scientists 114–115 D-Index: 79 scientists 116–117 D-Index: 61 scientists 118–119 D-Index: 44 scientists 120–121 D-Index: 37 scientists 122–123 D-Index: 40 scientists 124–125 D-Index: 33 scientists 126–127 D-Index: 26 scientists 128–129 D-Index: 34 scientists 130–131 D-Index: 35 scientists 132–133 D-Index: 25 scientists 134–135 D-Index: 27 scientists 136–137 D-Index: 17 scientists 138–139 D-Index: 16 scientists 140–141 D-Index: 20 scientists 142–143 D-Index: 20 scientists 144–145 D-Index: 15 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 9 scientists 150–151 D-Index: 16 scientists 152–153 D-Index: 11 scientists 154–155 D-Index: 9 scientists 156–157 D-Index: 3 scientists 158 D-Index: 3 scientists 159+ D-Index: 98 scientists
40 D-Index 159+

This scientist: 77 D-Index — 78th percentile

78% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 159 D-Index or more.

Overview

Michael A. Jakupec is affiliated with the University of Vienna in Austria. Their research primarily spans the field of Materials Science, with a focus on Materials Chemistry. Additional areas of study include Oncology, Organic Chemistry, Molecular Biology, and Biomaterials.

The scientist's recent publications include the following works:

  • Microplastics role in cell migration and distribution during cancer cell division, 2024, Chemosphere
  • Plecstatin-1 induces an immunogenic cell death signature in colorectal tumour spheroids, 2020, Metallomics
  • Tetra-(p-tolyl)antimony(III)-Containing Heteropolytungstates, [{(p-tolyl)SbIII}4(A-α-XW9O34)2]n (X = P, As, or Ge): Synthesis, Structure, and Study of Antibacterial and Antitumor Activity, 2020, Inorganic Chemistry
  • Thermodynamic Genome-Scale Metabolic Modeling of Metallodrug Resistance in Colorectal Cancer, 2021, Cancers
  • Morpho-metabotyping the oxidative stress response, 2021, Scientific Reports

Frequent coauthors in their work include:

  • Bernhard K. Keppler
  • Michaela Hejl
  • Wolfgang Kandioller
  • Natalie Gajic
  • Sophia Harringer

Michael A. Jakupec has published extensively in several key venues, notably:

  • The Cambridge Structural Database (69 publications)
  • Dalton Transactions (6 publications)
  • Pharmaceutics (5 publications)
  • Inorganic Chemistry (3 publications)
  • JBIC Journal of Biological Inorganic Chemistry (2 publications)

Their research covers a variety of main topics including:

  • Crystallization and Solubility Studies
  • X-ray Diffraction in Crystallography
  • Metal complexes synthesis and properties
  • Ferrocene Chemistry and Applications
  • Lanthanide and Transition Metal Complexes
  • Synthesis and biological activity
  • Nanoparticle-Based Drug Delivery

Best Publications

  • From bench to bedside – preclinical and early clinical development of the anticancer agent indazolium trans-[tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019 or FFC14A)

    Christian G. Hartinger;Stefanie Zorbas-Seifried;Michael A. Jakupec;Bernd Kynast

  • KP1019, a new redox-active anticancer agent--preclinical development and results of a clinical phase I study in tumor patients.

    Christian G. Hartinger;Christian G. Hartinger;Michael A. Jakupec;Stefanie Zorbas‐Seifried;Michael Groessl

  • Update of the preclinical situation of anticancer platinum complexes: novel design strategies and innovative analytical approaches.

    Markus Galanski;Michael A. Jakupec;Bernhard K. Keppler

  • NKP-1339, the first ruthenium-based anticancer drug on the edge to clinical application

    Robert Trondl;Petra Heffeter;Christian R. Kowol;Michael A. Jakupec

  • Antitumour metal compounds: more than theme and variations.

    Michael A. Jakupec;Markus Galanski;Vladimir B. Arion;Christian G. Hartinger

  • Recent Developments in the Field of Tumor-Inhibiting Metal Complexes

    M. Galanski;V. B. Arion;M. A. Jakupec;B. K. Keppler

  • Tumour-inhibiting platinum complexes--state of the art and future perspectives.

    M. A. Jakupec;M. Galanski;B. K. Keppler

  • Resistance against novel anticancer metal compounds: differences and similarities

    Petra Heffeter;Ute Jungwirth;Michael Jakupec;Christian Hartinger

  • Heterocyclic complexes of ruthenium(III) induce apoptosis in colorectal carcinoma cells

    S. Kapitza;M. Pongratz;M. A. Jakupec;P. Heffeter

  • Transferrin binding and transferrin-mediated cellular uptake of the ruthenium coordination compound KP1019, studied by means of AAS, ESI-MS and CD spectroscopy

    Martina Pongratz;Petra Schluga;Michael A. Jakupec;Vladimir B. Arion

  • Pharmacological properties of cerium compunds

    M. A. Jakupec;P. Unfried;B. K. Keppler

  • Redox behavior of tumor-inhibiting ruthenium(III) complexes and effects of physiological reductants on their binding to GMP

    Petra Schluga;Christian G. Hartinger;Alexander Egger;Erwin Reisner

  • Impact of metal coordination on cytotoxicity of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (triapine) and novel insights into terminal dimethylation

    Christian R. Kowol;Robert Trondl;Petra Heffeter;Vladimir B. Arion

  • Structure-activity relationships for NAMI-A-type complexes (HL)[trans-RuCl4L(S-dmso)ruthenate(III)] (L = imidazole, indazole, 1,2,4-triazole, 4-amino-1,2,4-triazole, and 1-methyl-1,2,4-triazole): aquation, redox properties, protein binding, and antiproliferative activity.

    Michael Groessl;Erwin Reisner;Christian G. Hartinger;Rene Eichinger

  • Transferring the concept of multinuclearity to ruthenium complexes for improvement of anticancer activity.

    Maria G. Mendoza-Ferri;Christian G. Hartinger;Marco A. Mendoza;Michael Groessl

  • Influence of the Spacer Length on the in Vitro Anticancer Activity of Dinuclear Ruthenium−Arene Compounds

    Maria-Grazia Mendoza-Ferri;Christian G. Hartinger;Rene E. Eichinger;Natalya Stolyarova

  • Redox-Active Antineoplastic Ruthenium Complexes with Indazole: Correlation of in Vitro Potency and Reduction Potential

    Michael A. Jakupec;Erwin Reisner;Anna Eichinger;Martina Pongratz

  • Gallium(III) and Iron(III) Complexes of α-N-Heterocyclic Thiosemicarbazones: Synthesis, Characterization, Cytotoxicity, and Interaction with Ribonucleotide Reductase

    Christian R. Kowol;Roland Berger;Rene Eichinger;Alexander Roller

  • Highly Antiproliferative Ruthenium(II) and Osmium(II) Arene Complexes with Paullone-Derived Ligands

    Wolfgang F. Schmid;Roland O. John;Vladimir B. Arion;Michael A. Jakupec

  • Anticancer activity of the lanthanum compound [tris(1,10-phenanthroline)lanthanum(III)]trithiocyanate (KP772; FFC24).

    Petra Heffeter;Michael A. Jakupec;Wilfried Körner;Stefan Wild

Frequent Co-Authors

Bernhard K. Keppler
Bernhard K. Keppler University of Vienna
Christian G. Hartinger
Christian G. Hartinger University of Auckland
Vladimir B. Arion
Vladimir B. Arion University of Vienna
Walter Berger
Walter Berger Medical University of Vienna
Paul J. Dyson
Paul J. Dyson École Polytechnique Fédérale de Lausanne
Gunda Koellensperger
Gunda Koellensperger University of Vienna
Vadim Yu. Kukushkin
Vadim Yu. Kukushkin Saint Petersburg State University
Erwin Reisner
Erwin Reisner University of Cambridge
Michael Wagner
Michael Wagner University of Vienna
Gerhard Wiche
Gerhard Wiche Max F. Perutz Laboratories

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Chemistry in the USA opens doors to a variety of related fields, many of which offer flexible online learning options. For those considering a career shift or complementing their chemistry background, exploring an criminal justice associate degree online can provide a unique perspective in forensic science and law enforcement roles.

If you're interested in legal support roles connected to chemistry or pharmaceuticals, pursuing a paralegal salary associate's degree might be a practical choice. It equips graduates with essential skills to assist in regulatory or patent law relating to chemical innovations.

For those drawn to the business side of pharmaceuticals, becoming a pharmaceutical sales representative can be lucrative. Understanding the pharma sales rep salary and career pathways can motivate chemistry graduates to leverage their scientific knowledge in sales roles that require strong communication skills.

Lastly, pursuing advanced studies to meet pharmacist education requirements is a natural extension for chemistry majors aiming to work directly in healthcare. Pharmacists apply their chemical expertise to patient care and medication management, making this a rewarding and stable career path.

Best Scientists Citing Michael A. Jakupec

Trending Scientists

Recently Published Articles